White Oak Provides Nanotherapeutics Financing
Nanotherapeutics announced it secured a $28.5 million debt financing from White Oak Global Advisors. The funds will support the completion of the company’s 180,000-square-feet flexible biologics manufacturing facility located in Alachua.
The NANO-ADM (Advanced Development and Manufacturing) facility, as it is known, will expand Nanotherapeutics’ core competencies in the development and cGMP manufacture of preclinical and clinical stage biopharmaceutical products. The company provides a full range of drug development services and intends to further capitalize on its capabilities through partnerships with government and established companies, as well as continuing to fund the development of its internal pipeline.
Nanotherapeutics develops, manufactures and distributes biodefense, infectious disease and influenza products, globally.